Armistice Capital, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Armistice Capital, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $11.4 Million - $15.7 Million	1,828,000 Added 21.83%	10,200,000 $71.5 Million
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $6.37 Million - $9.97 Million	-1,200,000 Reduced 12.54%	8,372,000 $69.4 Million
Q4 2021 Feb 14, 2022	SELL	$5.21 - $7.45 $2.23 Million - $3.19 Million	-428,000 Reduced 4.28%	9,572,000 $64.8 Million
Q3 2020 Nov 16, 2020	BUY	$2.97 - $5.08 $11.3 Million - $19.3 Million	3,800,000 Added 61.29%	10,000,000 $29.7 Million
Q2 2020 Aug 14, 2020	BUY	$3.48 - $5.05 $2.78 Million - $4.04 Million	800,000 Added 14.81%	6,200,000 $28.6 Million
Q1 2020 May 15, 2020	BUY	$2.61 - $5.21 $783,000 - $1.56 Million	300,000 Added 5.88%	5,400,000 $20.8 Million
Q4 2019 Feb 14, 2020	BUY	$3.67 - $5.7 $18.7 Million - $29.1 Million	5,100,000 New	5,100,000 $19.1 Million
Q3 2019 Nov 14, 2019	SELL	$3.89 - $7.43 $19.5 Million - $37.2 Million	-5,000,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $9.4 Million - $21.3 Million	3,480,000 Added 228.95%	5,000,000 $19.2 Million
Q1 2019 May 15, 2019	BUY	$2.11 - $5.33 $295,400 - $746,200	140,000 Added 10.14%	1,520,000 $7.75 Million
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $560,640 - $1.06 Million	-292,000 Reduced 17.46%	1,380,000 $2.65 Million
Q3 2018 Nov 14, 2018	SELL	$2.81 - $3.78 $78,680 - $105,840	-28,000 Reduced 1.65%	1,672,000 $6.32 Million
Q2 2018 Aug 14, 2018	BUY	$2.26 - $3.84 $3.84 Million - $6.53 Million	1,700,000 New	1,700,000 $5.3 Million

327

94.1M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.